Neural Therapeutics, Inc. (NURL.CX)

0.025 +0.01 (+66.67%) CAD  |  CNSX  |  Dec 10, 10:59
More

Neural Therapeutics Return on Net Operating Assets

Return on Net Operating Assets Chart

View Return on Net Operating Assets for NURL.CX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Return on Net Operating Assets Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Return on Net Operating Assets Range, Past 5 Years

View Return on Net Operating Assets Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Return on Net Operating Assets Benchmarks

View Return on Net Operating Assets Benchmarks
Start Trial
BioMark Diagnostics, Inc. Upgrade
Justera Health Ltd. --
Wesana Health Holdings, Inc. --
Biocure Technology, Inc. Upgrade
Core One Labs, Inc. --